Clinical trials
Schizophrenia
Cognition
Pharmaceutical
Mild Cognitive Impairment
GABAA receptor modulators
Drug Discovery
Affective disorders
Antidepressants
Technical Support
Medical
Phase 2
Drug Development
Phase 1
Central Nervous System (CNS)
Pharmaceuticals